MeCure Industries PLC provides end-to-end pharmaceutical contract manufacturing solutions for companies seeking reliable production, regulatory discipline, and market-ready execution in Nigeria and across West Africa.
With nearly two decades of manufacturing experience, cGMP-compliant operations, ISO 9001:2015 accreditation, strong regulatory systems, and a growing multi-format manufacturing platform, MeCure is positioned to help partners bring high-quality pharmaceutical and wellness products to market with confidence.
In today's healthcare market, speed, quality, compliance, and dependable supply determine whether a product succeeds. MeCure Industries PLC works with partners who need a trusted manufacturing base capable of supporting product development, commercial production, packaging, regulatory readiness, and long-term supply.
Whether you are launching a new pharmaceutical brand, expanding an existing product portfolio, localising production, reducing import dependency, or seeking a dependable Nigerian manufacturing partner, MeCure offers the systems, people, and infrastructure required to support your growth.
Our manufacturing approach is simple: every product must meet defined quality standards, every process must be controlled, and every partner must have confidence in what leaves our facility.
MeCure Industries PLC has operated in Nigeria's pharmaceutical sector since 2005, building a strong reputation for quality-focused manufacturing, product reliability, and continuous innovation.
Our facilities operate with strong quality assurance, quality control, and regulatory systems. MeCure is cGMP-compliant and ISO 9001:2015 accredited, with structured processes designed to meet pharmaceutical manufacturing standards.
MeCure's regulatory function is a major strength. The company has successfully managed regulatory inspections, maintained strong response discipline, and continues to build credibility with relevant authorities.
MeCure has dedicated Beta-Lactam capabilities and local experience in producing important antibiotic formulations, including Amoxiclav-based products.
MeCure is investing in future-ready manufacturing infrastructure, including expanded Oral Solid Dosage capacity and multi-format production capability to support tablets, capsules, dry syrups, stick packs, sachet formats, and packaging operations.
MeCure offers partners a strategic Nigerian manufacturing base with ambitions for wider West African expansion, helping companies localise production, reduce import dependency, and improve supply chain responsiveness.
MeCure operates a structured Track & Trace ecosystem designed to support product authentication, traceability, anti-counterfeiting measures, and regulatory compliance. The company has strengthened this capability through dual-server architecture to improve uptime reliability and real-time traceability support across the supply chain. This enables partners to manufacture with greater visibility, stronger market protection, and enhanced distributor confidence.
MeCure provides flexible manufacturing solutions across key pharmaceutical and wellness formats.
High-quality tablet manufacturing for prescription, over-the-counter, and wellness products, supported by controlled production processes and quality checks.
Capsule production for pharmaceutical and nutraceutical partners seeking reliable dosage-form manufacturing.
Liquid formulation manufacturing for cough, cold, paediatric, and general therapeutic categories.
Manufacturing support for dry powders and reconstitutable formulations, including products requiring careful process control and packaging precision.
As part of MeCure’s capacity expansion roadmap, the company is developing stronger multi-format capability to support modern consumer-friendly dosage formats.
Integrated packaging and labelling solutions designed to support market readiness, product integrity, traceability, and brand presentation.
MeCure supports Track & Trace-enabled pharmaceutical manufacturing and packaging workflows, helping partners align with evolving regulatory expectations and strengthening product verification across the distribution chain.
MeCure’s Beta-Lactam capability is one of its major manufacturing strengths. With dedicated production focus and experience in antibiotic manufacturing, MeCure supports partners looking to produce high-quality antibiotic products under controlled conditions.
Our Beta-Lactam expertise includes experience with Amoxiclav and related antibiotic formulations, supported by quality systems, regulatory discipline, and process controls required for dependable pharmaceutical production.
For partners seeking local antibiotic production in Nigeria, MeCure provides a credible platform backed by technical experience and commercial understanding of the Nigerian pharmaceutical market.
Work with MeCure's technical and regulatory teams to evaluate product feasibility, dosage format, formulation requirements, and commercial production pathways.
Access high-volume manufacturing capability designed to support consistent product supply for institutional, distributor, retail, and regional markets.
From primary packaging to secondary packaging and labelling, MeCure supports product presentation, handling integrity, and market readiness.
MeCure provides guidance and documentation support to help partners navigate relevant regulatory expectations, including NAFDAC-related processes where applicable.
Every contract manufacturing project is supported by defined quality systems, controlled processes, in-process checks, and release discipline.
MeCure understands the realities of the Nigerian pharmaceutical market and supports partners with manufacturing timelines, production planning, and fulfilment coordination.
At MeCure, quality is built into the manufacturing process from the start. Our quality culture is guided by one principle: every product that leaves our facility carries our responsibility and affects someone's health.
Our quality approach includes:
MeCure’s quality systems are designed to give partners confidence that their products are manufactured with discipline, care, and accountability.
Pharmaceutical manufacturing requires more than equipment. It requires documentation, inspection readiness, process control, and the ability to respond quickly to regulatory expectations.
MeCure has built regulatory credibility through successful inspections, product approvals, and disciplined query responses. This strengthens our ability to support partners who need a manufacturing base that understands both compliance and commercial urgency.
MeCure is not standing still. The company is investing in expanded manufacturing capacity to support future growth, reduce outsourcing dependency, and enable faster product launches.
support future growth, reduce outsourcing dependency, and enable faster product launches. The company’s strategic manufacturing roadmap includes expanded Oral Solid Dosage capacity and a longer-term plan for multi-line pharmaceutical manufacturing, including tablets, capsules, dry syrups, stick packs, packaging lines, and specialised future facilities.
For contract manufacturing partners, this means MeCure is building a platform that can support not only today’s production needs, but tomorrow’s product pipeline.
MeCure has experience manufacturing and supporting a broad range of pharmaceutical molecules and therapeutic categories across tablets, capsules, suspensions, syrups, creams, and antibiotic formulations.
Many pharmaceutical businesses are now rethinking supply chains, FX exposure, import timelines, and local manufacturing requirements. MeCure helps partners move toward a stronger local manufacturing model.
A typical pathway can include:
Assess product feasibility, market opportunity, documentation needs, and regulatory requirements.
Begin production, packaging, or partial localisation based on product readiness and commercial strategy.
Increase volumes, add related SKUs, improve cost efficiency, and build long-term market presence.
This model helps partners reduce risk while building stronger local supply capability.
We understand your product, target market, dosage form, expected volume, regulatory status, and launch objectives.
Our team reviews feasibility, manufacturing requirements, quality expectations, packaging needs, and timelines.
We align on required documents, specifications, testing requirements, and applicable regulatory steps.
Where necessary, trial batches or technical validation steps are carried out before full-scale production.
Approved products move into planned production with defined batch records, in-process controls, and quality review.
Products are packaged, checked, released, and prepared for onward distribution according to agreed specifications.
MeCure Industries PLC has worked with and supported a growing number of pharmaceutical companies, distributors, and healthcare brands seeking reliable local manufacturing support.
These partnerships span multiple therapeutic categories and dosage forms, including antibiotics, anti-infectives, cardiovascular products, pain management products, oral suspensions, tablets, capsules, and liquid formulations.
If you are looking for a trusted pharmaceutical contract manufacturing partner in Nigeria, MeCure Industries PLC is ready to speak with you.
Whether you need tablets, capsules, syrups, powders, Beta-Lactam products, packaging support, or a long-term localisation strategy, our team can help you take the next step.
Contact Our Contract Manufacturing TeamYour vision. Our expertise. Manufacturing excellence for healthcare growth.